Bisoprolol Fumarate/Hydrochlorothiazide

富马酸比索洛尔/氢氯噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBisoprolol Fumarate/Hydrochlorothiazide
Drug Alias Name氢氯噻嗪/富马酸比索洛尔Bisoprolol fumarate - hydrochlorothiazide mixtBisoprolol fumarate and hydrochlorothiazide富马酸比索洛尔氢氯噻嗪比索洛尔/氢氯噻嗪 +[7] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsBeta-1 adrenergic receptor antagonists
TargetsThiazide-sensitive sodium-chloride cotransporterBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1993/03/26
Country/TerritoryUnited StatesMainland China
CombinationsYes HydrochlorothiazideBisoprolol Fumarate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesTeva Branded Pharmaceutical Products R&D IncMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC07BB07
Related LinksKEGG